$FOXOW

FOXO TECHNOLOGIES INC.

CIK:0001812360|SEC Filings

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Net revenues	$ 4,715,016	$ 5,218,373	$ 9,883,052	$ 8,388,293
Operating expenses:
Direct costs of revenues	2,395,326	1,975,325	4,929,539	3,879,261
Research and development	23,700	40,183	59,250	70,183
Management contingent share plan (forfeiture) expense	(9,129,890)	18,878	(9,129,890)	37,756
Selling, general and administrative expenses	2,677,438	2,616,866	5,552,562	5,380,952
Total operating expenses	(4,033,426)	4,651,252	1,411,461	9,368,152
Income (loss) from operations	8,748,442	567,121	8,471,591	(979,859)
Change in fair value of warrant liabilities		7,576		39,170
Gain from extinguishment of Senior PIK Notes				1,863,834
Interest expense	(1,310,833)	(1,008,751)	(2,283,968)	(1,898,543)
Gain from legal settlements, net	1,648,377		1,630,127
Other non-operating expense, net	(949,093)	(92,252)	(1,136,043)	(171,716)
Total non-operating expenses, net	(611,549)	(1,093,427)	(1,789,884)	(167,255)
Income (loss) before income taxes	8,136,893	(526,306)	6,681,707	(1,147,114)
Provision for income taxes
Net income (loss), including noncontrolling interest	8,136,893	(526,306)	6,681,707	(1,147,114)
Net loss attributable to noncontrolling interest	(3,192)	(4,285)	(6,405)	(8,635)
Net income (loss) attributable to FOXO	8,140,085	(522,021)	6,688,112	(1,138,479)
Declared and deemed dividends from preferred stock, including issuances and anti-dilution provisions thereof and triggers of down-round provisions of Assumed Warrants	(135,605)	(265,070)	(135,605)	(437,195)
Net income (loss) to common stockholders	8,004,480	(787,091)	6,552,507	(1,575,674)
Preferred stock dividends – undeclared, net	259,052	(168,521)	(25,720)	(483,430)
Net income (loss) to common stockholders, net of preferred stock dividends – undeclared, net	$ 8,263,532	$ (955,612)	$ 6,526,787	$ (2,059,104)
Common Class A [Member]
Operating expenses:
Net income (loss) per share of Class A Common Stock, basic	$ 5.99	$ (634.12)	$ 5.40	$ (2,044.79)
Net income (loss) per share of Class A Common Stock, diluted	$ 0.09	$ (634.12)	$ 0.07	$ (2,044.79)
Weighted average shares of Class A Common Stock, basic	1,379,806	1,507	1,209,590	1,007
Weighted average shares of Class A Common Stock, diluted	96,966,756	1,507	104,390,520	1,007

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025	Dec. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss) including noncontrolling interest	$ 8,136,893	$ (526,306)	$ 6,681,707	$ (1,147,114)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization			346,887	289,818
Gain from extinguishment of Senior PIK Notes				(1,863,834)
Equity-based compensation, net of forfeitures	(9,100,000)		(9,129,890)	46,594
Gain on legal settlements, net	(1,648,377)		(1,630,127)
Amortization of consulting fees paid in common stock				212,590
Change in fair value of warrants		(7,576)		(39,170)
Amortization of debt discounts and debt issuance costs			1,023,464	824,986
Non-cash interest expense on right-of-use lease obligations			393,595	436,519
Non-cash interest			939,664	445,426
RCHI additional purchase price consideration			119,314
Changes in operating assets and liabilities:
Accounts receivable, net			(1,670,251)	(2,650,119)
Inventory and supplies			23,158	(4,590)
Prepaid expenses			(110,631)	1,367
Other current assets			(40,693)	(54,446)
Accounts payable			896,104	351,336
Accrued and other liabilities, including related parties’ payables			2,501,228	24,880
Right-of-use lease obligations			(622,753)	(602,546)
Other liabilities				12,000
Net cash used in operating activities			(279,224)	(3,716,303)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of furniture and equipment			(9,374)	(14,900)
Net cash used in investing activities			(9,374)	(14,900)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from notes payable, net of issuance costs			1,280,000	1,090,000
Proceeds from other loans				279,000
Borrowings on note payable to RHI			2,127,477	2,578,759
Payments on notes payable to RHI			(2,364,585)	(2,543,982)
Payments on notes payable			(667,841)	(111,872)
Payments on other loans			(235,497)	(408,056)
Proceeds from issuance of preferred stock, net of issuance costs				3,100,875
Net cash provided by financing activities			139,554	3,984,724
Net change in cash and cash equivalents			(149,044)	253,521
Cash and cash equivalents at beginning of period			207,453	68,268	$ 68,268
Cash and cash equivalents at end of period	$ 58,409	$ 321,789	$ 58,409	$ 321,789	$ 207,453

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current assets
Cash and cash equivalents	$ 58,409	$ 207,453
Accounts receivable, net	4,138,597	2,468,346
Inventory and supplies	160,469	183,627
Prepaid expenses	208,322	97,691
Other current assets	196,056	155,363
Total current assets	4,761,853	3,112,480
Property and equipment, net	286,865	322,357
Intangible assets, net	9,755,363	9,770,969
Goodwill	27,794,975	27,823,444
Right-of-use assets	3,290,677	3,548,623
Total assets	45,889,733	44,577,873
Current liabilities
Accounts payable	7,807,326	6,966,211
Accrued expenses	12,428,790	11,902,383
Notes payable	11,640,472	2,151,838
Related parties’ notes and loans payable	5,524,146	4,902,392
Other loans	42,958	237,810
Related parties’ payables and accrued expenses	2,597,158	1,998,775
Right-of-use lease obligations	574,247	499,351
Total current liabilities	40,615,097	28,658,760
Contingent purchase price consideration	500,000	500,000
Right-of-use lease obligations, non-current	2,870,495	3,174,549
Medicare cost report settlement payables	990,922	1,168,264
Total liabilities	44,976,514	33,501,573
Commitments and contingencies (Note 14)
Stockholders’ equity (deficit)
Class A common stock, $0.0001 par value, 25,000,000,000 shares authorized, 1,420,652 and 831,887 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively	142	83
Additional paid-in-capital	219,080,387	235,789,628
Accumulated deficit	(218,092,232)	(224,644,739)
Total FOXO’s stockholders’ equity	988,306	11,144,982
Noncontrolling interest	(75,087)	(68,682)
Total stockholders’ equity	913,219	11,076,300
Total liabilities and stockholders’ equity	45,889,733	44,577,873
Series A Preferred Stock [Member]
Stockholders’ equity (deficit)
Preferred stock, value	1	2
Series B Preferred Stock [Member]
Stockholders’ equity (deficit)
Preferred stock, value
Series C Preferred Stock [Member]
Stockholders’ equity (deficit)
Preferred stock, value
Series D Preferred Stock [Member]
Stockholders’ equity (deficit)
Preferred stock, value	1	1
Series E Preferred Stock [Member]
Stockholders’ equity (deficit)
Preferred stock, value	$ 7	$ 7